Cargando…
Expanding the Antimalarial Drug Arsenal—Now, But How?
The number of available and effective antimalarial drugs is quickly dwindling. This is mainly because a number of drug resistance-associated mutations in malaria parasite genes, such as crt, mdr1, dhfr/dhps, and others, have led to widespread resistance to all known classes of antimalarial compounds...
Autores principales: | Grimberg, Brian T., Mehlotra, Rajeev K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102560/ https://www.ncbi.nlm.nih.gov/pubmed/21625331 http://dx.doi.org/10.3390/ph4050681 |
Ejemplares similares
-
The Expanding Arsenal of Cytotoxic T Cells
por: Cassioli, Chiara, et al.
Publicado: (2022) -
Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations
por: Vishwas, Sukriti, et al.
Publicado: (2021) -
COVID19 therapeutics: Expanding the antiviral arsenal
por: Gallagher, Tom
Publicado: (2021) -
The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs
por: Spillman, Natalie Jane, et al.
Publicado: (2015) -
The shape of human squalene epoxidase expands the arsenal against cancer
por: Brown, Andrew J., et al.
Publicado: (2019)